Anavex Life Sciences Stock (NASDAQ: AVXL) stock price, news, charts, stock research, profile.
Open | $4.10 |
Close | $4.19 |
Volume / Avg. | 554.90K / 1.19M |
Day Range | 4.00 - 4.20 |
52 Wk Range | 3.25 - 10.45 |
Market Cap | $367.56M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 25.53% |
Days to Cover | 19.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.
Other companies in Anavex Life Sciences’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Korro Bio (NASDAQ:KRRO), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
There is no analysis for Anavex Life Sciences.
Anavex Life Sciences has a consensus price target of $29.75.
The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $4.3425 last updated July 5, 2024 at 5:07 PM EDT.
There are no upcoming dividends for Anavex Life Sciences.
Anavex Life Sciences’s Q3 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Anavex Life Sciences.
Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.